UK: 32 died of blood clots after receiving AstraZeneca COVID-19 vaccine
- What are the WHO recommendations for Japanese encephalitis vaccines?
- Individuals Carrying Two APOE4 Copies Likely to Develop Alzheimer’s Disease Symptoms
- What Is The Role of Lactic Acid in Tumor Growth and Therapy Resistance?
- The Enigma of Beethoven’s Deafness: Unveiling the Role of Lead Poisoning
- World First Autologous Regenerated Islet Transplantation Successful
- FDA Approved Opdualag: The First Immunotherapy Targeting LAG-3
UK: 32 died of blood clots after receiving AstraZeneca COVID-19 vaccine
UK: 32 died of blood clots after receiving AstraZeneca COVID-19 vaccine. The number of people who died of blood clots after being vaccinated with AstraZeneca vaccine rose to 32 in the UK.
Xinhua News Agency, London, April 22, the British Medicines and Health Products Administration updated the figures on the 22nd, showing that 168 people in the country have experienced thrombotic symptoms after being vaccinated with the COVID-19 vaccine jointly developed by AstraZeneca and Oxford University. 32 people died.
he British Medicines and Health Products Administration stated that as of April 14, 21.2 million people in the UK had received the first dose of AstraZeneca’s COVID-19 vaccine. Among the 168 people with thrombotic symptoms, 75 were men and 93 were women. Among them, 77 had cerebral venous sinus thrombosis, and 91 had severe thrombosis with thrombocytopenia.
However, the agency said, “Based on the results of this continuous evaluation, the current recommendation is that for most people, the benefits of vaccination outweigh the risks.”
Based on the agency’s recommendations, and out of concerns about blood clots, the British government this month agreed to provide other vaccines to most people under the age of 30 to replace AstraZeneca’s COVID-19 vaccine when conditions permit. The UK currently vaccinates the public with the COVID-19 vaccine and AstraZeneca’s COVID-19 vaccine jointly developed by Pfizer Pharmaceutical Co., Ltd. of the United States and the German Biotech Company.
When Kluge, the director of the World Health Organization’s European Regional Office, responded to the risks of vaccination against the COVID-19 at a video press conference on the 15th of this month, he once again emphasized that the benefits of vaccination outweigh the risks. Kluger said that among the 200 million people who have been vaccinated with AstraZeneca’s nCOVID-19 vaccine, only a few rare blood clotting disorders have occurred; at present, the risk of thrombosis due to COVID-19 is much higher than that of the AstraZeneca vaccine. ; “There is no doubt that AstraZeneca’s COVID-19 vaccine is effective in reducing severe cases and deaths from COVID-19.”
(source:internet, reference only)
Disclaimer of medicaltrend.org
